| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.068 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |